SEOM clinical guidelines in advanced and recurrent breast cancer (2018) von Chacón López-Muñiz, J. I., de la Cruz Merino, L., Gavilá Gregori, J., Martínez Dueñas, E., Oliveira, M., Seguí Palmer, M. A., Álvarez López, I., Antolin Novoa, S., Bellet Ezquerra, M., López-Tarruella Cobo, S.

Volltext

Preclinical and clinical development of palbociclib and future perspectives von de Dueñas, E. Martínez, Gavila-Gregori, J., Olmos-Antón, S., Santaballa-Bertrán, A., Lluch-Hernández, A., Espinal-Domínguez, E. J., Rivero-Silva, M., Llombart-Cussac, A.

Volltext

Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer von Alvarez-Lopez, I., Bezares, S., Dalmau Portulas, E., García-Martínez, E., García-Sáenz, J. Á., Gil-Gil, M., Martínez de Dueñas, E., Ribelles, N., Santaballa Bertrán, A.

Volltext

Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2−) early b... von Ruíz-Borrego, Manuel, Guerrero-Zotano, Angel, Bermejo, Begoña, Ramos, Manuel, Cruz, Josefina, Baena-Cañada, Jose Manuel, Cirauqui, Beatriz, Rodríguez-Lescure, Álvaro, Alba, Emilio, Martínez-Jáñez, Noelia, Muñoz, Montserrat, Antolín, Silvia, Álvarez, Isabel, Del Barco, Sonia, Sevillano, Elena, Chacón, José Ignacio, Antón, Antonio, Escudero, María José, Ruiz, Victoria, Carrasco, Eva, Martín, Miguel

Volltext

1882 CASCADE study: Epidemiological analysis of current natural history and treatment patterns of metastatic breast cancer in spain von Martínez Dueñas, E, Zamora, P, Servitja, S, Santaballa, A, García Mata, J, De Paz, L, Plata, Y, Garau, I, Florian, J, Chacón, J.I, De la Haba, J, García, P, San José, B, Riva, F, Rodríguez-Villanueva, J, Seguí, M.A

Volltext

Postsostenibilidad: notas antropológicas para imaginar otros futuros comunes von Martínez Dueñas, William Andrés, Perafán Ledezma, Astrid Lorena

Volltext

Impact of the 21-gene assay on treatment decisions in high-risk patients with ER-positive HER2-negative early breast cancer: Results of the KARMA Dx study von Llombart, A., Andrés, R., Anton Torres, A., Martinez, N., Rodriguez, C., Sánchez-Rovira, P., Rojas, B., Ruiz Borrego, M., Bermejo, B., Martinez de Dueñas, E.

Volltext

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer von Martín, Miguel, Seguí, Miguel A, Antón, Antonio, Ruiz, Amparo, Ramos, Manuel, Adrover, Encarna, Aranda, Ignacio, Rodríguez-Lescure, Alvaro, Große, Regina, Calvo, Lourdes, Barnadas, Agustí, Isla, Dolores, Martinez del Prado, Purificación, Ruiz Borrego, Manuel, Zaluski, Jerzy, Arcusa, Angels, Muñoz, Montserrat, López Vega, José M, Mel, José R, Munarriz, Blanca, Llorca, Cristina, Jara, Carlos, Alba, Emilio, Florián, Jesús, Li, Junfang, López García-Asenjo, José A, Sáez, Amparo, Rios, María José, Almenar, Sergio, Peiró, Gloria, Lluch, Ana

Volltext

199P Relation between CYP2D6 polymorphisms and survival in breast cancer treated with tamoxifen von Rubio Novella, S., Blancas López-Barajas, M.I., Ochoa, E., Herrero Vicent, C., Olmos, S., Martinez Dueñas, E.

Volltext

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer von Ross, L., Eisen, A., Elsafy, F., Fielding, A., Friedman, S., Gianni, L., Phillips, K.-A., Singer, C.F., Toi, M., Park, Y.H., Yang, H., Mailliez, A., Nagy, T., Sonke, G.S., Sun, Q., Colleoni, M.A., Kaufman, B., Cameron, D., Campbell, C., Sevelda, Paul, Öhler, Leopold, Rumpold, Holger, Rautenberg, Beate, Boadle, David, Mackey, John, Niraula, Saroj, Randal d’Hondt, Papadimitriou, Konstantinos, Lazzaro, Mauricio Fernández, Pilnik, Norma, Varela, Mirta, Darsow, Maren, Park-Simon, Tjoung-Won, Terhaag, Jürgen, Salat, Christoph, Dieterich, Max, García Sáenz, José Ángel, Lanza, Angels Arcusa, Quiroga, Vanesa, Jañez, Noelia Martínez, Crusades, Gema Llort, Rodríguez, César, Cretella, Elisabetta, Jegannathen, Apurna, Ishida, Kazushige, Watanabe, Junichiro, Takada, Masahiro, Nakamura, Seigo, Aogi, Kenjiro, Tsugawa, Koichiro, Seaward, Samantha A., Carney, Jennifer Fu, Bobolis, Kristie A., Eisenberg, Peter D., Hofstatter, Erin W., McCarron, Edward C., Herbolsheimer, Pia, Meisel, Jane L., Jones, Cheryl F., Spector, David M., Lo, Shelly S., Cristofanilli, Massimo, Hahn, Olwen M., Oliff, Ira A., Ansari, Bilal, Sharma, Priyanka, Armstrong, Deborah K., VanderWoude, Amy, Friday, Bret E.B., T, Benjamin, Kuzma, Charles S., Radford, James E., Soori, Gamini S., Vogel, Victor G., Wilkinson, Mary, Qamar, Rubina, Loman, Niklas, Silander, Gustav, Abreu, Miguel, Ciruelos Gil, Eva María, Bermejo de las Heras, Begoña, Busch, Steffi, Thomalla, Jörg, Altena, Renske, Chen, Shou-Tung, Huang, Chiun-Sheng, Yeh, Dah-Cherng, Pottier, Virginie, Yang, Hongjian, Fu, Peifen, Wang, Yongsheng, Fan, Zhimin, Landherr, László, Yerushalmi, Rinat, Conte, Pierfranco, Ciccarese, Mariangela, Mackiewicz, Jacek, Kalinka, Ewa, Im, Seock-Ah, Lee, Kyoung Eun

Volltext

Abstract GS2-04: Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients wi... von Martín, M, Barrios, CH, Torrecillas, L, Ruiz-Borrego, M, Bines, J, Segalla, J, Ruiz, A, García-Sáenz, JA, Torres, R, de la Haba, J, García, E, Gómez, HL, Llombart, A, Rodríguez de la Borbolla, M, Baena, JM, Barnadas, A, Calvo, L, Pérez-Michel, L, Ramos, M, Castellanos, J, Rodríguez-Lescure, A, Cárdenas, J, Vinholes, J, Martínez de Dueñas, E, Godes, MJ, Seguí, MA, Antón, A, López-Álvarez, P, Moncayo, J, Amorim, G, Villar, E, Reyes, S, Sampaio, C, Cardemil, B, Escudero, MJ, Bezares, S, Carrasco, E, Lluch, A

Volltext

Abstract P6-05-02: Intrinsic subtype and gene expression changes between primary and metastatic breast cancer von Prat, A, Martínez de Dueñas, E, Galván, P, Garcia, S, Burgués, O, Paré, L, Antolín, S, Martinello, R, Blancas, I, Adamo, B, Guerrero, Á, Muñoz, M, Nuciforo, P, Vidal, M, Pérez, RM, Chacón, JI, Caballero, R, Gascón, P, Carrasco, E, Rojo, F, Perou, CM, Cortés, J, Adamo, V, Albanell, J, Lluch, A

Volltext

428P Key landmarks of male advanced breast cancer: Results of the GEICAM/2016-04 study von Martinez, N., Martinez del Prado, M.P., Melia, C. Hernando, Penabad, S. Recalde, Muñoz, A.S., Pancorbo, D. Morales, Eslava, M. Santisteban, Perez, I. Fernandez, Del Barco Berron, S., Adelantado, E. Zamora, Iranzo, V., Cardenas, T. Martos, Martinez de Dueñas, E., Antolín-Novoa, S., Zotano, A.L. Guerrero, Alonso, R. Ferreira, Esteban, C. Esteban, Frances, S. Enrech, Hernández, A.A. Tejera, Urruticoechea, A.

Volltext

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable ap... von Schneeweiss, A., Peretz-Yablonski, T., Nowecki, Z., Merot, J.-L., Pena-Murillo, C., Bachelot, T., Coudert, B., Nowecki, Z., Wardley, A., Puglisi, F., Montemurro, F., Hu, X., Gaafar, R., Li, H., Aktas, B., Tienghi, A., Miles, D., Lux, M., Menjon Beltran, S., Turner, N., Tong, Z., Boer, K., Horvath, Z., Susnjar, S., Matos, E., Garcia Estevez, L., Cruz, M., Bourgeois, H., von Schumann, R., Morales-Vásques, F., Voitko, N., Hicks, J., Barrett-Lee, P., Wheatley, D., Gozy, M., Latini, L., Barnadas Molins, A., Bratos, R., McCarthy, N., Kee, D., Artignan, X., Azribi, F., Jaafar, H., Augereau, P., Müller, V., Evron, E., Cascinu, S., El-Saghir, N., Ghosn, M., Oosterkamp, H.M., Kukulska, M., Levitt, N., Panwar, U., Rigg, A., Fein, L., Malik, L., Singer, C., Stoeger, H., Cedeño, M., Berdah, J.-F., Goncalves, A., Orfeuvre, H., Fried, G., Moscetti, L., Siddiqi, N., Arcediano Del Amo, A., McAdam, K., Dunn, G., Taylor, W., Hegg, R., Grosjean, J., Laplaige, P., Christensen, B., Zahm, D.-M., Inbar, M., Bonetti, A., van der Velden, A., van Warmerdam, L., Viñas Vilaro, G., Bachmeier, K., Beresford, M., Joffe, J., Nobre, A., Jiang, J., Padrik, P., Dohollou, N., Prulhiere, K., Ober, A., Alabiso, O., van de Wouw, A.J., Saadein, A., Abdelhafiez, N., Abulkhair, O., Llorente Domenech, R., Gil Raga, M., Rodriguez Sanchez, C., Torrego Garcia, J., Vicente Rubio, E., Jones, A., Alonso, I.

Volltext

282PPROSPECTIVE EVALUATION OF TWO MULTI-GENE ASSAYS IN NODE-NEGATIVE, ESTROGEN RECEPTOR-POSITIVE (ER+) BREAST CANCER PATIENTS TO AID ADJUVANT CLINICAL DECISION MAKING IN A COMMUNIT... von de Dueñas, E. Martinez, Lluch-Hernandez, A., Llombart, A., Rodriguez-Lescure, A., Salas, D., Garcia, J. Miranda

Volltext

Prospective Evaluation of Two Multi-Gene Assays in Node-Negative, Estrogen Receptor-Positive (Er+) Breast Cancer Patients to Aid Adjuvant Clinical Decision Making in a Community-Ba... von de Dueñas, E. Martinez, Lluch-Hernandez, A., Llombart, A., Rodriguez-Lescure, A., Salas, D., Garcia, J. Miranda

Volltext

208TiP SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician’s choice (TPC) in pretreated HER2-positiv... von Ciruelos, E.M., Ponce, J., Pernas Simon, S., Cortés, J., Cantos, B., Garate, E., Vega Alonso, E., Mele Olive, M., Martinez De Dueñas, E., Montaño Perianez, A., Martinez, N., Perello Martorell, A., Bermejo De Las Heras, B., Arqueros Nunez, C., Fernández, I., De la Haba Rodriguez, J., Oliveira, M., González, X., Villagrasa Gonzalez, P., Prat, A.

Volltext

95P PAM50 HER2-enriched phenotype as a predictor of early response to neoadjuvant lapatinib plus trastuzumab HER2-positive breast cancer: Survival results of the SOLTI-PAMELA study von Pascual, T., Bermejo De Las Heras, B., Martinez, N., Oliveira, M., Pernas Simon, S., Lopez Lopez, R., Ruiz Cabrero, I., Alarcon, J.D., Martinez De Dueñas, E., Malon Gimenez, D., Gonzalez Cao, M., Manso Sanchez, L.M., Morales Murillo, S., Lopez de Ceballos, H., Cortés, J., Llombart Cussac, A., Prat, A.

Volltext

28PImpact of the 21-gene assay on treatment decisions in high-risk patients with ER-positive HER2-negative early breast cancer: Results of the KARMA Dx study von Llombart, A, Andrés, R, Anton Torres, A, Martinez, N, Rodriguez, C, Sánchez-Rovira, P, Rojas, B, Ruiz Borrego, M, Bermejo, B, Martinez de Dueñas, E

Volltext

Overall survival in the OlympiA phase Ill trial of adjuvant olaparib in patients with germime pathogenic variants in BRCA1/2 and high-risk, early breast cancer von Geyer, C. E., Garber, J. E., Gelber, R. D., Yothers, G., Taboada, M., Ross, L., Rastogi, P., Cui, K., Arahmani, A., Aktan, G., Armstrong, A. C., Arnedos, M., Balmana, J., Bergh, J., Bliss, J., Delaloge, S., Domchek, S. M., Eisen, A., Elsafy, F., Fein, L. E., Fielding, A., Ford, J. M., Friedman, S., Gelmon, K. A., Gianni, L., Gnant, M., Hollingsworth, S. J., Im, S. A., Jager, A., Lakhani, S. R., Janni, W., Linderholm, Barbro, Liu, T. W., Loman, N., Korde, L., Loibl, S., Lucas, P. C., Marme, F., de Duenas, E. M., McConnell, R., Phillips, K. A., Piccart, M., Rossi, G., Schmutzler, R., Senkus, E., Shao, Z., Sharma, P., Singer, C. F., Spanic, T., Stickeler, E., Toi, M., Traina, T. A., Viale, G., Zoppoli, G., Park, Y. H., Yerushalmi, R., Yang, H., Pang, D., Jung, K. H., Mailliez, A., Fan, Z., Tennevet, I., Zhang, J., Nagy, T., Sonke, G. S., Sun, Q., Parton, M., Colleoni, M. A., Schmidt, M., Brufsky, A. M., Razaq, W., Kaufman, B., Cameron, D., Campbell, C., Tutt, A. N. J., Johannsson, O. T.

Volltext